Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/190118
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaynou Pujolràs, Laia-
dc.contributor.authorOwen, Rhiannon-
dc.contributor.authorKonstant-Hambling, Rob-
dc.contributor.authorImam, Towhid-
dc.contributor.authorArkill, Suzanne-
dc.contributor.authorBertfield, Deborah-
dc.contributor.authorStreet, Andrew-
dc.contributor.authorAbrams, Keith R-
dc.contributor.authorConroy, Simon-
dc.date.accessioned2022-10-25T07:51:22Z-
dc.date.available2022-10-25T07:51:22Z-
dc.date.issued2022-10-01-
dc.identifier.issn1878-7649-
dc.identifier.urihttp://hdl.handle.net/2445/190118-
dc.description.abstractIntroduction Frailty has emerged as an important construct to support clinical decision-making during the COVID-19 pandemic. However, doubts remain related to methodological limitations of published studies. Methods Retrospective cohort study of all people aged 75 + admitted to hospital in England between 1 March 2020 and 31 July 2021. COVID-19 and frailty risk were captured using International Classification of Disease-10 (ICD-10) diagnostic codes. We used the generalised gamma model to estimate accelerated failure time, reporting unadjusted and adjusted results. Results The cohort comprised 103,561 individuals, mean age 84.1, around half female, 82% were White British with a median of two comorbidities. Frailty risk was distributed approximately 20% low risk and 40% each at intermediate or high risk. In the unadjusted survival plots, 28-day mortality was almost 50% for those with an ICD-10 code of U071 (COVID-19 virus identified), and 25-35% for those with U072 (COVID-19 virus not identified). In the adjusted analysis, the accelerated failure time estimates for those with intermediate and high frailty risk were 0.63 (95% CI 0.58-0.68) and 0.67 (95% CI 0.62-0.72) fewer days alive respectively compared to those with low frailty risk with an ICD-10 diagnosis of U072 (reference category). Conclusion In older people with confirmed COVID-19, both intermediate and high frailty risk were associated with reduced survival compared to those with low frailty risk.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1007/s41999-022-00668-8-
dc.relation.ispartofEuropean Geriatric Medicine, 2022, vol. 13, num. 5, p. 1149-1157-
dc.relation.urihttps://doi.org/10.1007/s41999-022-00668-8-
dc.rightscc-by-nc-nd (c) European Union Geriatric Medicine Society (EUGMS) , 2022-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Econometria, Estadística i Economia Aplicada)-
dc.subject.classificationCOVID-19-
dc.subject.classificationMortalitat-
dc.subject.classificationFragilitat-
dc.subject.classificationFactors de risc en les malalties-
dc.subject.otherCOVID-19-
dc.subject.otherMortality-
dc.subject.otherBrittleness-
dc.subject.otherRisk factors in diseases-
dc.titleThe association between frailty risk and COVID-19-associated all-mortality in hospitalised older people: a national cohort study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec724167-
dc.date.updated2022-10-25T07:51:22Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Econometria, Estadística i Economia Aplicada)

Files in This Item:
File Description SizeFormat 
724167.pdf689.01 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons